Ranbaxy Niryat Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
- Paid Up Capital ₹ 5.51 Cr
- Company Age 30 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 28.30 K
- Revenue Growth 192.85%
- Profit Growth 80.90%
- Ebitda -127.51%
- Net Worth -0.00%
- Total Assets -0.00%
About Ranbaxy Niryat
Ranbaxy Niryat Pvt. Ltd. (RNPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 March 1994 and has a history of 30 years and ten months. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 5.51 Cr.
The company currently has active open charges totaling ₹28,300.00.
Chanchal Mondal and Rishab Jaiswal serve as directors at the Company.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51109WB1994PTC062376
-
Company No.
062376
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Mar 1994
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Ranbaxy Niryat?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chanchal Mondal
|
Director | 28-May-2019 | Current |
|
Rishab Jaiswal
|
Director | 15-Jun-2023 | Current |
Financial Performance of Ranbaxy Niryat.
Ranbaxy Niryat Pvt. Ltd., for the financial year ended 2016, experienced significant growth in revenue, with a 192.85% increase. The company also saw a substantial improvement in profitability, with a 80.9% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ranbaxy Niryat?
In 2017, Ranbaxy Niryat had a public holding of 100.00%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Hibiscus Mercantile Private LimitedChanchal Mondal and Rishab Jaiswal are mutual person
-
Moonstar Corporate Consultants Pvt Ltd
Chanchal Mondal and Rishab Jaiswal are mutual person
-
Rubicon Vinimay Private Limited
Chanchal Mondal is a mutual person
-
Searose Vincom Private Limited
Chanchal Mondal is a mutual person
-
Supreme Dealtrade Private Limited
Chanchal Mondal and Rishab Jaiswal are mutual person
-
Calandium Sales Private Limited
Chanchal Mondal and Rishab Jaiswal are mutual person
Charges (Loans)
₹0.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 0.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Nov 2022 | Others | ₹0.03 M | Open |
How Many Employees Work at Ranbaxy Niryat?
Unlock and access historical data on people associated with Ranbaxy Niryat, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ranbaxy Niryat, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ranbaxy Niryat's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
